Tirzepatide is a dual GIP and GLP-1 receptor agonist designed to support metabolic regulation, appetite control, glycaemic stability, and body composition improvement.

This formulation is supplied as a self-mix vial kit, containing:

1 vial Tirzepatide 30 mg (lyophilized)
1 vial 2 mL bacteriostatic water

Designed for structured weekly dosing with gradual titration.

What It Does

Tirzepatide activates both:

GLP-1 receptors (appetite regulation, gastric emptying modulation, insulin sensitivity)
GIP receptors (enhanced insulin response and metabolic signaling support)

Combined receptor activity supports:

Appetite reduction
Improved satiety
Blood glucose regulation
Reduced caloric intake
Fat mass reduction
Improved metabolic efficiency

Reconstitution Protocol (Self-Mix)

Clean vial tops with an alcohol swab.
Draw the full 2 mL bacteriostatic water into a syringe.
Slowly inject down the side of the Tirzepatide vial.
Do not shake. Gently swirl until fully dissolved.
Refrigerate after mixing.

Final concentration after mixing:
30 mg in 2 mL
15 mg per mL

On a 100-unit insulin syringe:
1 unit = 0.15 mg

Dose Conversion Reference

Units (Clicks)	mg Dose
5 units	0.75 mg
10 units	1.5 mg
15 units	2.25 mg
20 units	3.0 mg
25 units	3.75 mg
30 units	4.5 mg
40 units	6.0 mg
50 units	7.5 mg

Structured Dosing Protocol (Weekly Injection)

Tirzepatide is administered once weekly.

Weeks 1–4: 1.5 mg weekly (10 units)
Weeks 5–8: 3.0 mg weekly (20 units)
Weeks 9–12: 4.5 mg weekly (30 units)
Weeks 13–16: 6.0 mg weekly (40 units)

Advanced escalation (if required and tolerated): 7.5 mg weekly (50 units)

Do not escalate faster than necessary 2/4 weeks. Gradual increases improve tolerability and metabolic adaptation.

Administration

Subcutaneous injection
Once weekly
Abdomen, thigh, or upper arm
Rotate injection sites

Position Within The Clinic System

Tirzepatide is a metabolic regulation protocol.

It may be combined with:

Somatropin for body composition support
Structural repair stacks during recomposition phases
Regenerative protocols where weight reduction supports tissue recovery

It is not a structural repair peptide. It is a metabolic control protocol.

Tirzepatide 30 mg - Self Mix

Brand: The Clinic
Product Code: TIRSM-030
Reward Points: 100
Availability: In Stock

Qty

0 reviews / Write a review

The Clinic

Tirzepatide is a dual GIP and GLP-1 receptor agonist designed to support metabolic regulation, appetite control, glycaemic stability, and body composition improvement.

What It Does

Reconstitution Protocol (Self-Mix)

Dose Conversion Reference

Structured Dosing Protocol (Weekly Injection)

Administration

Position Within The Clinic System